Company

Technology powers us. Drug development defines us.

Novorex is a drug development company integrating AI, FBDD, and biophysical validation to identify real binders and advance high-unmet-need CNS and inflammation pipelines.

05 / Company Capability

Deep Technology, Hard Science

Novorex connects dry-lab prediction, wet-lab validation, and development execution to support real-binder discovery.

05 / 05

Integrated company strength

Dry-lab prediction, wet-lab validation, and development execution

Novorex connects dry-lab prediction, wet-lab validation, and development execution into a focused real-binder discovery organization.

Dry Lab

AI generation, molecular selection, pose inspection, docking, scoring, ADMET and BBB-related prediction.

Wet Lab

Protein production, fragment screening, SPR, NMR, X-ray, biochemical and cellular assay capabilities.

Development Execution

SAR, medicinal chemistry, CADD, hit-to-lead optimization, and partner-facing data package development.